Q4 2024 Management View CEO Joseph Dowling highlighted the company’s focus on scaling its business, achieving cost efficiencies, and transitioning to a global health and wellness company. He noted a ...

Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Thursday it's ...

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness ...

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness ...

Greetings and welcome to the CV Sciences’ Fourth Quarter and Year-End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and ...

The global vegan food market is expected to grow 5 times by 2030 with millennials and flexitarians as the driving force behind soaring vegan foods sales," said Joseph Dowling, CEO of CV Sciences.

About CV Sciences, Inc. CV Sciences, Inc. (OTCQB:CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven ...

Greetings and welcome to the CV Sciences fourth quarter and year end, 2024 financial results conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer ...

Such forward-looking statements by definition involve risk and uncertainties. CV Sciences does not undertake any obligation to publicly update any forward-looking statements, except as required by ...